Log in to save to my catalogue

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1774531944

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

About this item

Full title

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Publisher

United States: American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2016-03, Vol.351 (6279), p.1339-1342

Language

English

Formats

Publication information

Publisher

United States: American Association for the Advancement of Science

More information

Scope and Contents

Contents

Ebola virus disease in humans is highly lethal, with case fatality rates ranging from 25 to 90%. There is no licensed treatment or vaccine against the virus, underscoring the need for efficacious countermeasures. We ascertained that a human survivor of the 1995 Kikwit Ebola virus disease outbreak maintained circulating antibodies against the Ebola...

Alternative Titles

Full title

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1774531944

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1774531944

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aad5224

How to access this item